Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6

Molecular Metabolism

Volumn 4, Issue 11, 2015, Pages 846-856

  Anderson, Jason G ^a   Ramadori, Giorgio ^a,b   Ioris, Rafael M ^b   Galiè, Mirco ^b   Berglund, Eric D ^a,c   Coate, Katie C ^a   Fujikawa, Teppei ^a   Pucciarelli, Stefania ^d   Moreschini, Benedetta ^d   Amici, Augusto ^d   Andreani, Cristina ^d   Coppari, Roberto ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Diabetes; Glucose homeostasis; Insulin sensitivity; SIRT6 overexpression; Sirtuin

Indexed keywords

INSULIN; PROTEIN KINASE B; SIRTUIN 6; SPERMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GASTROCNEMIUS MUSCLE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLEUS MUSCLE; WILD TYPE;

EID: 84945305740     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.09.003     Document Type: Article

References (37)

1. Vianna C.R., Coppari R. A treasure trove of hypothalamic neurocircuitries governing body weight homeostasis. Endocrinology 2011, 152(1):11-18.
2. Coppari R., Bjorbaek C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nature Reviews Drug Discovery 2012, 11(9):692-708.
3. Maahs D.M., Rewers M. Editorial: Mortality and renal disease in type 1 diabetes mellitus-progress made, more to be done. The Journal of Clinical Endocrinology and Metabolism 2006, 91(10):3757-3759.
4. Steffes M.W., Sibley S., Jackson M., Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003, 26(3):832-836.
5. Bluestone J.A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464(7293):1293-1300.
6. Ramadori G., Lee C.E., Bookout A.L., Lee S., Williams K.W., Anderson J., et al. Brain SIRT1: anatomical distribution and regulation by energy availability. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28(40):9989-9996.
7. Ramadori G., Konstantinidou G., Venkateswaran N., Biscotti T., Morlock L., Galie M., et al. Diet-induced unresolved ER stress hinders KRAS-driven lung tumorigenesis. Cell Metabolism 2015, 21(1):117-125.
8. Ramadori G., Gautron L., Fujikawa T., Vianna C.R., Elmquist J.K., Coppari R. Central administration of resveratrol improves diet-induced diabetes. Endocrinology 2009, 150(12):5326-5333.
9. Ramadori G., Fujikawa T., Fukuda M., Anderson J., Morgan D.A., Mostoslavsky R., et al. SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metabolism 2010, 12(1):78-87.
10. Ramadori G., Fujikawa T., Anderson J., Berglund E.D., Frazao R., Michan S., et al. SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metabolism 2011, 14(3):301-312.
11. Ramadori G., Coppari R. Pharmacological manipulations of CNS sirtuins: potential effects on metabolic homeostasis. Pharmacological Research 2010, 62(1):48-54.
12. Coppari R., Ramadori G., Elmquist J.K. The role of transcriptional regulators in central control of appetite and body weight. Nature Clinical Practice Endocrinology & Metabolism 2009, 5(3):160-166.
13. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444(7117):337-342.
14. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127(6):1109-1122.
15. Ramadori G., Coppari R. Does hypothalamic SIRT1 regulate aging?. Aging 2011, 3(3):325-328.
16. Kugel S., Mostoslavsky R. Chromatin and beyond: the multitasking roles for SIRT6. Trends in Biochemical Sciences 2014, 39(2):72-81.
17. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124(2):315-329.
18. Zhong L., D'Urso A., Toiber D., Sebastian C., Henry R.E., Vadysirisack D.D., et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010, 140(2):280-293.
19. Sundaresan N.R., Vasudevan P., Zhong L., Kim G., Samant S., Parekh V., et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nature Medicine 2012, 18(11):1643-1650.
20. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91.
21. Jiang H., Khan S., Wang Y., Charron G., He B., Sebastian C., et al. SIRT6 regulates TNF-alpha secretion through hydrolysis of long-chain fatty acyl lysine. Nature 2013, 496(7443):110-113.
22. Kanfi Y., Peshti V., Gil R., Naiman S., Nahum L., Levin E., et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010, 9(2):162-173.
23. Dominy J.E., Lee Y., Jedrychowski M.P., Chim H., Jurczak M.J., Camporez J.P., et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Molecular Cell 2012, 48(6):900-913.
24. Balthasar N., Coppari R., McMinn J., Liu S.M., Lee C.E., Tang V., et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004, 42(6):983-991.
25. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73(1):56-65.
26. Fujikawa T., Berglund E.D., Patel V.R., Ramadori G., Vianna C.R., Vong L., et al. Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metabolism 2013, 18(3):431-444.
27. Berglund E.D., Vianna C.R., Donato J., Kim M.H., Chuang J.C., Lee C.E., et al. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. The Journal of Clinical Investigation 2012, 122(3):1000-1009.
28. Seiler N. Liquid chromatographic methods for assaying polyamines using prechromatographic derivatization. Methods in Enzymology 1983, 94:10-25.
29. Kanfi Y., Shalman R., Peshti V., Pilosof S.N., Gozlan Y.M., Pearson K.J., et al. Regulation of SIRT6 protein levels by nutrient availability. FEBS Letters 2008, 582(5):543-548.
30. Kraus D., Yang Q., Kong D., Banks A.S., Zhang L., Rodgers J.T., et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 2014, 508(7495):258-262.
31. Price N.L., Gomes A.P., Ling A.J., Duarte F.V., Martin-Montalvo A., North B.J., et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metabolism 2012, 15(5):675-690.
32. Banks A.S., Kon N., Knight C., Matsumoto M., Gutierrez-Juarez R., Rossetti L., et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metabolism 2008, 8(4):333-341.
33. Coppari R. Metabolic actions of hypothalamic SIRT1. Trends in Endocrinology and Metabolism: TEM 2012, 23(4):179-185.
34. Pfluger P.T., Herranz D., Velasco-Miguel S., Serrano M., Tschop M.H. Sirt1 protects against high-fat diet-induced metabolic damage. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(28):9793-9798.
35. Masri S., Rigor P., Cervantes M., Ceglia N., Sebastian C., Xiao C., et al. Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 2014, 158(3):659-672.
36. Xiao C., Kim H.S., Lahusen T., Wang R.H., Xu X., Gavrilova O., et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. The Journal of Biological Chemistry 2010, 285(47):36776-36784.
37. Sahar S., Sassone-Corsi P. Regulation of metabolism: the circadian clock dictates the time. Trends in Endocrinology and Metabolism: TEM 2012, 23(1):1-8.